<DOC>
	<DOC>NCT01853722</DOC>
	<brief_summary>This proof-of-concept study evaluates the clinical efficacy and safety of DCN01 in prepping of the periocular region.</brief_summary>
	<brief_title>A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to UnisolÂ® Following Topical Periocular Administration in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Have given a written, informed consent Be willing and able to follow all instructions A negative urine pregnancy test if female of childbearing potential Known sensitivities to study medication or its components Any signs of an active infection Use of disallowed products during the period indicated prior to the enrollment or during the study Be currently pregnant, nursing, or planning a pregnancy; or be a woman that has a positive pregnancy test Have a condition or a situation which, in the Investigator's opinion, may put the subject at increased risk, confound study data, or interfere significantly with the subject's study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>DCN01</keyword>
	<keyword>Ocular Surgical Preparation</keyword>
	<keyword>Prophylaxis against infection</keyword>
	<keyword>Pre-operative prep</keyword>
</DOC>